<unk>  is a proton pump inhibitor that is FDA approved for the treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis and risk reduction of rebleeding of gastric or duodenal ulcers following therapeutic endoscopy in adults.   Common adverse reactions include injection site reaction, abdominal pain, constipation, diarrhea, flatulence, indigestion, nausea, xerostomia, dizziness, headache.
Esomeprazole sodium
Rabeprazole
Lansoprazole
Omeprazole
Hexetidine
Pantoprazole 
Sucralfate
Magnesium hydroxide